Anlotinib alone or in combination with bevacizumab in the treatment of recurrent high-grade glioma: a prospective single-arm, open-label phase II trial
Article in BMC Cancer (January 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Article in BMC Cancer (January 2024)
Article in Frontiers in Oncology (December 2023)
Article in Journal of Bone Oncology (November 2023)